Calpain: a death protein that mediates progression of liver injury

• Published in: Trends in pharmacological sciences (Regular ed.) 2005-05, Vol.26 (5), p.232-236
• Main Authors: Mehendale, Harihara M., Limaye, Pallavi B.
• Format: Article
• Language: English
• Subjects: Animals; Calpain - antagonists & inhibitors; Calpain - metabolism; Chemical and Drug Induced Liver Injury - metabolism; Disease Progression; Humans
• ISSN: 0165-6147; 1873-3735
• DOI: 10.1016/j.tips.2005.03.008

Calpain is a Ca 2+-regulated cytosolic cysteine protease that exists mainly in two isoforms and mediates crucial cellular functions, including rearrangement of cytoskeletal proteins, transport of the glucose transporter GLUT4, and protein cleavage to activate various receptors and pro-enzymes. Unintentional activation or functional loss of intracellular calpain has been implicated in several pathologies, including neurodegenerative diseases, traumatic brain and spinal cord injuries, cataracts and ischemia-associated injuries. Furthermore, polymorphism in the gene encoding calpain-10 has been associated with increased risk of type 2 diabetes. Recent studies have revealed a novel role for calpain in the progression of toxicant-induced liver damage. Evidence suggests that calpain leaking out of necrotic hepatocytes is highly activated in the extracellular milieu and hydrolyzes proteins in the plasma membrane of neighboring cells leading to progression of injury. Experimental intervention with calpain inhibitors substantially mitigates progression of liver injury initiated by toxicants, thereby preventing acute liver failure, and toxicant-induced animal death, pointing to a new potential therapeutic strategy against acute toxicities.